Dr. Jonathan Rosenberg, MD
Claim this profileMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Area of expertise
Bladder Cancer
Jonathan Rosenberg, MD has run 4 trials for Bladder Cancer. Some of their research focus areas include:
Transitional Cell Carcinoma
Jonathan Rosenberg, MD has run 3 trials for Transitional Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Memorial Sloan Kettering Cancer Center
Clinical Trials Jonathan Rosenberg, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting
1 award
Phase 2
10 criteria
Enfortumab Vedotin
for Bladder Cancer
This trial is testing enfortumab vedotin, a drug that targets and kills cancer cells, in patients with upper urinary tract urothelial carcinoma who can't or won't use cisplatin and are planning surgery. Enfortumab vedotin is a new type of drug that targets a specific protein on cancer cells and delivers a substance that kills these cells.
Recruiting
1 award
Phase 2
More about Jonathan Rosenberg, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Jonathan Rosenberg, MD has experience with
- Enfortumab Vedotin
- Gemcitabine
- Ipilimumab
- Nivolumab
- Radical Cystectomy
- Radical Surgery
Breakdown of trials Jonathan Rosenberg, MD has run
Bladder Cancer
Transitional Cell Carcinoma
Locally Advanced
Unresectable
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Rosenberg, MD specialize in?
Jonathan Rosenberg, MD focuses on Bladder Cancer and Transitional Cell Carcinoma. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jonathan Rosenberg, MD currently recruiting for clinical trials?
Yes, Jonathan Rosenberg, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Rosenberg, MD has studied deeply?
Yes, Jonathan Rosenberg, MD has studied treatments such as Enfortumab Vedotin, Gemcitabine, Ipilimumab.
What is the best way to schedule an appointment with Jonathan Rosenberg, MD?
Apply for one of the trials that Jonathan Rosenberg, MD is conducting.
What is the office address of Jonathan Rosenberg, MD?
The office of Jonathan Rosenberg, MD is located at: Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center (All Protocol Activities).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.